KEYNOTE-564: Phase 3 trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma (RCC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Choueiri, TK; Powles, T; Zhang, T; Quinn, DI; Gschwend, JE; Wan, SS; Poehlein, C

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017